ITCMDBv1
Clinical TrialID 7916

Health Effects of Oat Bioactives (Betaglucan) in Human

NCT05801653

Healthy

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Herb: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
7916
Evidence Id
7916
Core Evidence Id
7916
Source Clinical Trial Id
7913
Herb2 Clinical Trial Id
HBCT007913
Nct Id
NCT05801653
Title
Health Effects of Oat Bioactives (Betaglucan) in Human
Status
Completed
Phase
Study Result
No
Study Condition
Healthy
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: PREVENTION
Intervention
DIETARY_SUPPLEMENT: Effects of Oat and Oat Components on Cardiometabolic risk variables
Intervention Allocation
Randomized
Intervention Model
Crossover
Intervention Mask
Single
Intervention Purpose
Prevention
Gender
All
Age
Adult
Enrollment
20
Outcome Measure
Blood glucose regulation, Postprandial blood glucose regulation (incremental area under the curve) acute after intake of the test products and at forthcoming meals within 5.5 hours after consumption of test products., Time Frame: 0 - 5.5 hours ( at fasting and then repeatedly after breakfast and Standardize lunch)
Sponsor Collaborator
Lund University|Swedish Foundation for Strategic Research
Funded By
OTHER
Location
Food Technology, engineering and Nutrition, LTH, Lund University, Lund, Skane, 22100, Sweden
Other Id
Dnr. 2018/658 (del 4)
Start Date
2023-03-08
Primary Completion Date
2023-06-15
Completion Date
2023-08-10
First Posted
2023-04-06
Results First Posted
Last Update Posted
2023-10-04
Study Document
Study Url
https://clinicaltrials.gov/study/NCT05801653
Title Cn
Title En
Health Effects of Oat Bioactives (Betaglucan) in Human
Bilingual Status
semi_complete